
Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical market worldwide
Overview
7
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2022
- Premium Statistic World pharmaceutical sales 2020-2022 by region
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2022
- Premium Statistic Revenues of top 10 global pharmaceutical markets 2021
- Basic Statistic Top pharmaceutical products by sales worldwide 2022
- Premium Statistic Share of pharmaceutical value worldwide 2021, by country
- Premium Statistic Value share of pharmaceutical subsectors worldwide 2003 vs. 2021
Segments
8
- Premium Statistic Top therapy classes by spending global market 2026 forecast
- Premium Statistic Global pharmaceutical revenue by technology 2012-2026
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Basic Statistic Projection of global revenue for orphan prescription drugs 2012-2026
- Basic Statistic Worldwide generic prescription drug sales 2012-2026
- Premium Statistic Revenue of the global OTC pharmaceutical market 2016-2027
- Premium Statistic Global oncology spending 2011-2023
- Premium Statistic Tota pharmaceutical value worldwide 2021, by subsector
Companies
8
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2021
- Basic Statistic Global Rx drug market share by top companies 2019 and 2026
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2022
- Premium Statistic Pfizer's total revenue 2006-2022
- Premium Statistic Novartis' revenue 2007-2022
- Premium Statistic Roche Group's total sales 2006-2022
- Premium Statistic Johnson & Johnson's total sales 2005-2022
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
R&D, patents, new products
8
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Basic Statistic Global top pharmaceutical companies based on R&D spending 2026
- Premium Statistic Patent expiration risks for total worldwide prescription drug revenue 2020-2028
- Basic Statistic Worldwide prescription drug revenue - market risk from patent expiration 2020-2028
- Premium Statistic Pharmaceutical industry - number of new substances 1998-2021
- Basic Statistic Pharma companies worldwide with active R&D pipelines 2001-2022
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2022
- Basic Statistic Projected most valuable R&D projects based on net present value 2022
Outlook
7
- Premium Statistic World pharmaceutical sales by region forecast 2026
- Premium Statistic Global spending on medicines 2010-2026
- Premium Statistic CAGR by product type in pharmaceutical markets forecast 2022-2026
- Premium Statistic Country comparison in spending on medicine 2026
- Premium Statistic Leading global pharmaceutical products by projected sales 2026
- Basic Statistic Top global biopharma drugs by lifetime sales up to 2026
- Basic Statistic Global top pharmaceutical companies based on R&D spending 2026
Focus: COVID-19 response
7
- Basic Statistic COVID-19 vaccine dose numbers by top manufacturer 2021
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
- Basic Statistic Number of COVID-19 drugs in development worldwide by phase June 2022
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
- Basic Statistic Gilead Science's remdesivir manufacturing projections 2020
- Basic Statistic Global mRNA vaccines and therapeutics market for COVID-19 Q4 2020 vs. 2025
Further related statistics
20
- Patients reached by Novartis AG's products 2009-2022
- Dividends paid by Novartis AG 2009-2022
- Novartis' sales revenue in Spain 2012-2020
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- Novartis AG - doses sold for prevention of major diseases 2013
- Novartis' number of full-time employees 2009-2022
- Novartis' number of full-time employees by division 2013-2014
- Novartis' spending on research and development by segment 2017-2022
- Italy: value of purchased goods and services of Novartis 2017, by region
- Italy: value of taxes paid by Novartis 2013-2017
- Distribution of employees of Novartis in Italy 2015-2017, by gender
- Italy: investments of Novartis in research and development 2013-2017
- Distribution of employees of Novartis in Italy 2017, by age group
- Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
- Italy: clinical trials of Novartis 2017, by therapeutic area
- Italy: clinical trials of Novartis approved by AIFA 2017, by stage
- Number of employees of Novartis in Italy 2017, by region
- Italy: investments of Novartis 2013-2017
- McKesson Europe's revenue 2022 by country
- Industry revenue of “preparation and spinning of textile fibres“ in Germany 2012-2025
Further Content: You might find this interesting as well
Statistics
- Patients reached by Novartis AG's products 2009-2022
- Dividends paid by Novartis AG 2009-2022
- Novartis' sales revenue in Spain 2012-2020
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- Novartis AG - doses sold for prevention of major diseases 2013
- Novartis' number of full-time employees 2009-2022
- Novartis' number of full-time employees by division 2013-2014
- Novartis' spending on research and development by segment 2017-2022
- Italy: value of purchased goods and services of Novartis 2017, by region
- Italy: value of taxes paid by Novartis 2013-2017
- Distribution of employees of Novartis in Italy 2015-2017, by gender
- Italy: investments of Novartis in research and development 2013-2017
- Distribution of employees of Novartis in Italy 2017, by age group
- Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
- Italy: clinical trials of Novartis 2017, by therapeutic area
- Italy: clinical trials of Novartis approved by AIFA 2017, by stage
- Number of employees of Novartis in Italy 2017, by region
- Italy: investments of Novartis 2013-2017
- McKesson Europe's revenue 2022 by country
- Industry revenue of “preparation and spinning of textile fibres“ in Germany 2012-2025
Novartis. (February 2, 2023). Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars) [Graph]. In Statista. Retrieved March 24, 2023, from https://www.statista.com/statistics/264238/novartis-revenues-since-2007/
Novartis. "Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars)." Chart. February 2, 2023. Statista. Accessed March 24, 2023. https://www.statista.com/statistics/264238/novartis-revenues-since-2007/
Novartis. (2023). Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: March 24, 2023. https://www.statista.com/statistics/264238/novartis-revenues-since-2007/
Novartis. "Novartis Ag's Total Revenue from 2007 to 2022 (in Billion U.S. Dollars)." Statista, Statista Inc., 2 Feb 2023, https://www.statista.com/statistics/264238/novartis-revenues-since-2007/
Novartis, Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/264238/novartis-revenues-since-2007/ (last visited March 24, 2023)
Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars) [Graph], Novartis, February 2, 2023. [Online]. Available: https://www.statista.com/statistics/264238/novartis-revenues-since-2007/